Full-body CT Market Size, Share, Growth, and Industry Analysis, By Type ( CT Scanners,PET-CT Scanners ), By Application ( Hospitals,Clinics ), Regional Insights and Forecast to 2035

Full‑body CT Market Overview

Global Full-body CT market size is forecasted to be worth USD 1040.75 million in 2026, expected to achieve USD 1752.28 million by 2035 with a CAGR of 6.5%.

The Full‑body CT Market Size has demonstrated significant quantitative adoption, with the global whole‑body imaging sector showing near 4,967.3 million units value in 2024, encompassing CT imaging modalities that cover entire anatomical scans. Computed Tomography remains a dominant modality within the whole‑body imaging ecosystem, with global installations and use cases reported across oncology, trauma, and emergency care imaging applications. Annual usage data indicates the extensive prevalence of CT imaging procedures in key healthcare systems; for instance, CT technologies account for tens of millions of examinations each year in high‑income countries. The Full‑body CT Market Insights highlight a diverse end‑use spectrum, including diagnostic centers and hospitals with thousands of active CT units deployed worldwide.

In the United States Full‑body CT Market, CT imaging figures show that more than 70 million CT scans are performed annually, with the U.S. ranking among the highest in global CT utilization and output of imaging procedures. CT scanner deployments span across hospital radiology departments, outpatient imaging centers, and specialized clinics, where the prevalence of CT imaging for trauma, oncology staging, cardiopulmonary and neurological diagnostics remains robust. Data indicates that the U.S. computed tomography market alone accounted for a sizeable share of global installations, with extensive infrastructure supporting fixed and mobile CT platforms, along with integration into emergency and routine screening workflows.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: 65 % of healthcare facilities report increased adoption of full‑body CT systems driven by rising chronic disease prevalence (oncology, cardiovascular, trauma imaging).
• Major Market Restraint: 28 % of smaller diagnostic centers cite budget limitations as a key restraint in acquiring full‑body CT equipment.
• Emerging Trends: 52 % of new installations incorporate AI‑enabled reconstruction and low‑dose protocols, indicating advanced tech integration.
• Regional Leadership: North America accounts for approximately 38 % share of global full‑body CT installations across key hospital and diagnostic facilities.
• Competitive Landscape: 47 % of the installed base is concentrated among top five OEMs (GE Healthcare, Siemens, Philips, Toshiba, Hitachi) in major markets.
• Market Segmentation: 60 % of full‑body CT scans are hospital‑based, while the remaining 40 % occur in clinics and diagnostic imaging centers.
• Recent Development: 33 % of reported product launches in 2024‑2025 focused on photon‑counting detectors and high‑slice CT systems.

Full‑body CT Market Latest Trends

The Full‑body CT Market Trends reveal that quantitative adoption of high‑slice and multi‑detector CT systems is robust across major healthcare infrastructures. In 2024, North America accounted for the largest share of CT deployments with over 3,200 units installed across key airports and hospital centers, representing nearly 38 % of global installations. Europe contributed more than 2,800 units (29 %), while Asia‑Pacific saw around 3,000 units (20 %), reflecting rapid adoption in China, India, and Japan driven by expansion of advanced diagnostic facilities and screening programs. Portable and AI‑enabled CT scanners now constitute 21 % of new market installations, particularly in public health and campus‑based emergency care settings.

Mobile CT services are increasingly adopted by 15 % of new clinics to support decentralized diagnostics in underserved regions. Hybrid systems combining CT with PET or other imaging modalities represent an expanding segment with over 2,600 units operational in oncology centers globally. Emergency trauma centers and oncology units report a year‑over‑year increase in scan volumes exceeding 10 %, underscoring the central role of full‑body CT in acute care and disease staging. AI integration, ultra‑high‑resolution imaging, and dose‑reduction innovations are key trends shaping the Full‑body CT Market Outlook.

Full‑body CT Market Dynamics

DRIVER

"Rising demand for advanced diagnostic imaging."

The global push toward earlier disease detection and comprehensive health screening has driven substantial demand for advanced full‑body CT technologies. Parameters indicate that tens of millions of CT procedures are conducted annually in major healthcare systems, particularly in high‑volume CT centers in the U.S., Europe, and Asia, where over 80 million CT scans per year are reported in the U.S. alone. Hospitals and diagnostic imaging centers rely on CT scanning for rapid trauma assessment, oncology staging, cardiovascular disease evaluation, and neurological diagnostics. Full‑body CT systems enable volumetric imaging of entire anatomical structures in a single session, significantly expanding diagnostic throughput. Continuous integration of AI‑assisted image reconstruction has enhanced diagnostic accuracy and workflow efficiency. With combined CT and PET systems now integral in many oncology departments, clinical pathways increasingly prioritize full‑body CT imaging for staging and treatment monitoring, further accelerating usage. Such systemic adoption reflects high utilization rates in large acute care facilities where CT scanning accounts for a significant percentage of all diagnostic imaging volumes.

RESTRAINT

"High equipment acquisition and operational costs."

Despite strong adoption, cost barriers remain a major restraint hindering broader deployment of full‑body CT systems, especially in smaller clinics and budget‑constrained diagnostic centers. Data shows that 28 % of centers cite budget limitations as a key constraint in acquiring new CT equipment. Entry and ownership costs for high‑slice CT platforms, coupled with ancillary infrastructure requirements (power backup, radiation shielding, technician training), add layers of financial burden. Additionally, operational expenditures such as maintenance contracts, calibration services, and software upgrades contribute to long‑term cost pressures. These barriers are most pronounced in emerging markets and small‑tier regions where capital investment budgets are limited. In some regions, cost constraints result in extended replacement cycles, with facilities operating legacy CT units for over 8 to 10 years before upgrades. Regulatory compliance costs for radiation safety and quality assurance audits further add to financial overheads, making full‑body CT system procurement and sustainment challenging for lower‑margin healthcare providers.

OPPORTUNITY

"Expansion of AI""‑enabled and low""‑dose CT innovations."

Technological innovation in full‑body CT imaging offers major opportunities across the diagnostic landscape. The integration of AI‑enabled reconstruction algorithms has led to reduced scan times and improved detection sensitivity, which appeals to high‑volume imaging centers. Low‑dose CT protocols are gaining traction, with many facilities adopting dose‑mitigating software that supports expanded usage in preventive screening programs. Photon‑counting CT technology is an emerging opportunity, offering enhanced contrast resolution and spectral imaging capabilities, positioning these systems for advanced clinical applications. Hybrid PET‑CT and multi‑modality imaging systems are also expanding use cases in oncology, cardiology, and neurology, addressing demand for comprehensive diagnostic platforms under a single imaging session. Expansion of mobile CT units and decentralized imaging services present opportunities to capture under‑served markets, especially in regional healthcare hubs. Innovative financing structures, leasing models, and partnerships between vendors and healthcare networks are unlocking new procurement pathways, enabling broader institutional adoption of advanced CT systems.

CHALLENGE

"Regulatory and supply""‑chain complexities."

Full‑body CT deployments face challenges tied to regulatory approvals, supply‑chain constraints, and workforce shortages. Regulatory pathways for new imaging technologies involve stringent safety assessments and multi‑stage quality checks, delaying introduction of next‑generation systems into clinical practice. International trade restrictions and geopolitical fluctuations can disrupt supply of key components such as detectors and semiconductors, contributing to installation delays. Workforce challenges, including limited numbers of trained radiologic technologists and physicists, impact operational throughput in many hospitals and imaging centers. Facilities often report a shortfall in qualified personnel necessary to manage advanced CT platforms, leading to increased reliance on specialized training programs. Coordination across multi‑vendor systems and software versions adds logistical challenges; up to 30 % of new installations require extended service support during the learning curve. These challenges require systematic planning and investment in workforce and supply‑chain resiliency for sustained adoption.

Full‑body CT Market Segmentation

Download Free Sample to learn more about this report.

The Full‑body CT Market Segmentation by type primarily includes CT Scanners and PET‑CT Scanners. CT Scanners dominate in sheer installation units deployed across hospitals and clinics due to their broad diagnostic utility and faster scan throughput, while PET‑CT Scanners play a critical role in oncology and metabolic imaging applications. By application, hospitals represent the largest share of usage due to high patient volumes and complex case requirements, whereas clinics and outpatient imaging centers contribute significant incremental adoption. Segmentation analysis highlights that integration of multi‑slice and hybrid imaging forms a large part of current market deployments.

BY TYPE

CT Scanners: CT Scanners form the backbone of the Full‑body CT Market due to widespread use in rapid anatomical diagnostics across acute care hospitals and imaging centers. Global CT scanner installations numbered in the tens of thousands, with data indicating that the global CT scanners industry accounted for over 7.6 billion USD equivalent in equipment value in 2024 and represented a dominant share of medical imaging modalities. CT Scanners are segmented into low‑slice, medium‑slice, and high‑slice systems, with high‑slice units preferred in tertiary hospitals for complex neurological, cardiovascular, and oncological imaging. Multi‑detector CT platforms enhance throughput and image resolution, making them essential for trauma and emergency departments handling high daily patient loads. CT scanners are prevalent in more than 80 % of midsize and larger hospitals in developed markets, where routine use includes cancer screening, cardiovascular evaluation, and trauma assessment. These systems also find expanding applications in lung screening and whole‑body wellness programs. OEM concentration shows that established vendors such as GE Healthcare, Siemens, Philips, and others command a substantial share of the installed CT scanner base, driven by service networks and product portfolios tailored to hospitals and diagnostic centers.

PET‑CT Scanners: PET‑CT Scanners combine metabolic imaging PET technology with anatomical CT imaging, forming a key segment of the Full‑body CT Market for oncology and advanced diagnostics. In the global PET‑CT scanner device domain, stationary PET‑CT platforms accounted for over 60 % share of installed systems by 2026, reflecting their adoption in major cancer centers and research hospitals. PET‑CT systems are integral for comprehensive tumor detection, staging, and therapy response monitoring, particularly where metabolic activity mapping is clinically crucial. The oncology application accounts for the largest share among PET‑CT modalities, with a substantial portion of the installed base in specialized imaging departments. Neurology and cardiology applications also benefit from PET‑CT systems due to their ability to combine anatomical detail with physiological information. Major imaging centers in North America and Europe house hundreds of PET‑CT units which drive high annual scan volumes, particularly in cancer diagnosis pathways. The PET‑CT segment’s deployment is supported by advanced digital detector technology, full‑ring scanners, and robust clinical workflows that emphasize precision diagnostics.

BY APPLICATION

Hospitals: In the Full‑body CT Market by Application, hospitals account for the largest share of utilization due to high volumes of inpatient and outpatient imaging requirements. Hospitals perform integrated CT imaging protocols for trauma assessment, oncology staging, cardiology evaluation, neurological diagnostics, and pre‑operative mapping. The imaging departments of large hospitals operate multi‑detector and high‑slice CT systems that enable multiple daily scan sessions and advanced modalities such as spectral imaging. These installations often represent more than 60 % of all full‑body CT deployment capacity in major health systems, with many tertiary care facilities owning multiple CT units to support specialized departments. Emergency care units within hospitals rely on rapid full‑body scanning to evaluate polytrauma patients, ensuring that critical time metrics are met. Oncology units within hospital systems maintain PET‑CT and advanced CT platforms with dedicated imaging workflows. Hospitals also serve as training grounds for technologists and radiologists, further reinforcing their central role in full‑body CT usage.

Clinics: Clinics and outpatient imaging centers constitute a significant and growing application segment for the Full‑body CT Market. Diagnostic clinics serve high‑volume patient flows for routine health screenings, preventive diagnostics, and follow‑up imaging protocols, contributing an estimated 40 % share of routine CT imaging utilization outside tertiary hospitals. These clinics often deploy medium‑slice CT scanners that balance image quality with operational economics, suitable for cardiovascular, pulmonary, and musculoskeletal imaging needs. The accessibility of clinic‑based CT imaging enhances patient convenience, reducing wait times and enabling rapid turnaround for routine scans. Clinics increasingly adopt portable and low‑dose CT technologies to support screening programs for lifestyle diseases such as lung cancer or coronary calcium scoring. Many standalone imaging centers integrate full‑body CT services with specialty diagnostic suites, attracting referrals from primary care and specialist practices. This outpatient segment continues to expand due to growing demand for early detection diagnostics and cross‑referral networks between clinics and larger hospital-based specialists.

Full‑body CT Market Regional Outlook

Download Free Sample to learn more about this report.

The Full‑body CT Market demonstrates varied adoption across global regions. North America leads with approximately 38 % of global installations, driven by high volumes of hospital and outpatient imaging procedures. Europe follows with around 29 % of total units, where Germany, France, and the UK dominate adoption. Asia‑Pacific represents 20 % share, led by China, India, and Japan, reflecting rapid expansion in hospitals and diagnostic clinics. Middle East & Africa account for roughly 13 % of global CT deployments, focusing on urban healthcare hubs and airport security installations. Regional adoption reflects infrastructure maturity, healthcare funding, and prevalence of advanced imaging systems.

NORTH AMERICA

North America is the largest regional market for full‑body CT systems, accounting for nearly 38 % of global installations with over 3,200 units deployed in hospitals, emergency care centers, and outpatient facilities. The United States alone performs more than 70 million CT scans annually, with high volumes in trauma care, oncology staging, and cardiovascular diagnostics. Canadian hospitals contribute significantly, with medium‑ and high‑slice CT systems deployed in over 80 % of major hospital radiology departments. Emergency departments commonly operate 2 to 3 CT scanners per facility, while hybrid PET‑CT systems are concentrated in oncology and research centers. Adoption is also supported by dense service networks, high infrastructure investment, and established radiology workflows. Outpatient clinics increasingly add medium‑slice CT units, representing about 40 % of incremental installations, to manage preventive screenings and follow‑up imaging. North America also leads in mobile and low‑dose CT implementations, with roughly 15 % of new scanners being portable units deployed in rural and semi‑urban areas to improve accessibility. Advanced AI and reconstruction technologies are integrated in more than 50 % of installations, enhancing diagnostic efficiency and throughput.

EUROPE

Europe accounts for approximately 29 % of global full‑body CT installations, totaling over 2,800 units. Germany leads the region with the highest number of CT scanners, with major hospitals deploying multiple high‑slice systems for complex neurological, cardiovascular, and oncological imaging. France and the UK follow with widespread adoption of medium- and high-slice CT platforms in hospitals and large outpatient imaging centers. European hospitals maintain 2–5 CT systems per major facility, ensuring high throughput in trauma, oncology, and cardiovascular departments. Hybrid PET‑CT systems are concentrated in oncology reference centers, accounting for over 25 % of regional PET‑CT deployments. Adoption is bolstered by standardized protocols for cancer and cardiovascular screening programs, with emergency care units relying on full‑body CT for polytrauma cases. Radiology consortia in Europe facilitate cross-border training and technology standardization, which increases system utilization and optimizes diagnostic workflows. Regulatory frameworks for radiation safety and periodic quality audits ensure operational consistency, enhancing clinical confidence. Low-dose CT adoption is expanding, particularly for screening programs, reflecting growing focus on preventive healthcare. Emerging markets within Eastern Europe are adding medium-slice CT scanners, contributing to regional growth and expanded access to full-body imaging services.

ASIA‑PACIFIC

The Asia‑Pacific region represents around 20 % of global full‑body CT installations, with approximately 3,000 units deployed. China and India lead adoption, driven by hospital expansion and high patient volumes. China has integrated thousands of CT units into tier‑1 and tier‑2 city hospitals, supporting oncology, cardiology, and trauma imaging. India has rapidly increased CT installations, particularly medium- and high-slice scanners, in response to rising disease incidence and preventive screening initiatives. Japan maintains one of the highest per-capita CT scanner densities among OECD countries, ensuring broad availability in hospitals and specialized imaging centers. Southeast Asia and Australia are expanding CT infrastructure to support growing healthcare needs, often integrating tele-radiology and remote image analysis. Outpatient diagnostic clinics in urban centers account for around 40 % of new installations, improving patient access to advanced imaging. Hybrid PET‑CT scanners are increasingly adopted in oncology departments, while low-dose CT protocols are utilized in public health screening initiatives. Overall, infrastructure investment, government funding, and healthcare modernization are driving rapid regional growth in full-body CT adoption.

MIDDLE EAST & AFRICA

Middle East & Africa account for approximately 13 % of global full-body CT installations, totaling around 1,500 units. Adoption is concentrated in urban healthcare hubs, including Saudi Arabia, UAE, and South Africa. Saudi Arabia has invested heavily in tertiary hospitals, deploying high-slice and multi-detector CT systems to improve trauma care, oncology diagnostics, and cardiovascular imaging. The UAE has expanded imaging networks in private hospitals and outpatient diagnostic centers, with medium-slice scanners representing over 50 % of installations. South Africa integrates full-body CT systems in major public hospitals and private imaging networks, enhancing diagnostic accessibility. Smaller clinics in the region are increasingly acquiring portable and modular CT units to reach semi-urban populations. Government funding, public-private partnerships, and hospital modernization programs are driving equipment adoption. Radiation safety regulations and operator training initiatives support safe utilization, ensuring clinical reliability. Regional challenges include limited infrastructure in rural areas, though mobile CT deployment and regional tele-radiology solutions are addressing gaps. Overall, the Middle East & Africa market is poised for incremental growth as investments in imaging technologies and healthcare modernization continue to rise.

List of Top Full‑body CT Companies

• GE Healthcare
• Siemens Healthcare
• Philips
• Toshiba
• Shimadzu
• Hitachi
• NeuroLogica
• Neusoft Medical
• Shenzhen Anke High-tech
• United-imaging

Top 2 Companies with Highest Market Share

• GE Healthcare: Among the top vendors with the highest market share in CT scanner installations globally, commanding a significant portion of the installed base in North America, Europe, and Asia‑Pacific hospitals and clinics.
• Siemens Healthcare: Holds a leading share of global full‑body CT installations with extensive deployments of high‑slice and hybrid imaging units across major acute care centers worldwide.

Investment Analysis and Opportunities

The Full‑body CT Market Investment Analysis underscores sustained institutional investment by healthcare networks, imaging chains, and private equity in advanced diagnostic imaging technologies. Quantitatively, CT scanner deployments have expanded into thousands of units across major markets, with North America and Europe accounting for dominant shares and Asia‑Pacific emerging rapidly. Dedicated oncology imaging centers increasingly invest in hybrid PET‑CT platforms, aligning with the growing incidence of cancer and demand for comprehensive staging. The outpatient and imaging clinic segment exhibits significant investment interest, with medium‑slice CT systems proliferating due to their balance of performance and cost efficiencies.

Strategic investments in AI integration, dose reduction software, and cloud‑based image management systems amplify diagnostic throughput and operational efficiencies, attracting capital inflows from both healthcare providers and technology integrators. Expansion of imaging services into regional and semi‑urban areas presents opportunity corridors, especially where mobile and mid‑tier CT systems unlock under‑served patient populations. Collaborative financing models, including equipment leasing and shared‑services imaging hubs, attract smaller clinics with limited capital budgets. Investment opportunities also include service networks and maintenance ecosystems, given the high ratio of installed CT units requiring periodic calibration, platform upgrades, and software enhancements. Public‑private partnerships focusing on preventative health screening programs utilizing full‑body CT imaging further support expansion of imaging assets in national health strategies.

New Product Development

New Product Development in the Full‑body CT Market is marked by a wave of innovations that enhance diagnostic clarity, workflow efficiency, and radiation safety. Leading OEMs have introduced high‑slice and photon‑counting CT platforms capable of capturing volumetric images of entire body regions with improved resolution and time efficiency. Photon‑counting detectors represent a leap forward, offering enhanced contrast detail and spectral imaging capabilities that benefit oncology and cardiovascular imaging protocols. AI‑enabled reconstruction software has been integrated into many new CT systems, facilitating automated image processing, real‑time quality control, and rapid diagnostic throughput in high‑volume imaging centers. These advanced algorithms support noise reduction and improved lesion detection, enabling clinicians to interpret complex imaging data with greater confidence. Many CT platforms now offer low‑dose imaging protocols tailored for screening programs and pediatric imaging, where radiation exposure concerns are paramount.

Hybrid systems combining CT with PET and other modalities have extended clinical use cases, particularly in multi‑disciplinary oncology care pathways. Portable and modular CT units designed for urgent care settings have also emerged, enabling rapid imaging in field hospitals and emergency departments with constrained infrastructure. Cloud‑connected CT systems that streamline image sharing and remote analysis expand collaboration across radiology networks and referral centers. These innovations position the Full‑body CT Market at the forefront of advanced imaging technologies, with quantifiable adoption metrics across diverse clinical applications.

Five Recent Developments

• Introduction of photon‑counting CT platforms in multiple regions enhancing spectral imaging resolution and diagnostic detail across oncology and cardiology units.
• Deployment of AI‑assisted CT reconstruction suites reducing scan times by significant percentages and enhancing image clarity in daily clinical workflows.
• Expansion of hybrid PET‑CT systems in regional cancer centers with increased annual scan volumes reported.
• Rolling out of mobile CT units in community health programs to support underserved populations and remote clinical diagnostics.
• Increased integration of cloud‑connected imaging networks enabling cross‑facility image sharing and remote radiologist collaboration.

Report Coverage of Full‑body CT Market

This Full‑body CT Market Report covers a comprehensive scope of global and regional dynamics within the full‑body imaging ecosystem. It encompasses segmentation by type (CT Scanners, PET‑CT Scanners) and application (Hospitals, Clinics) with quantifiable adoption data showing the relative distribution of installations in key segments. Regional insights include detailed metrics for North America, Europe, Asia‑Pacific, and Middle East & Africa, highlighting units deployed, adoption rates, and usage patterns in diverse healthcare infrastructures.

The report includes competitive landscape analysis with quantitative metrics illustrating concentration among leading vendors such as GE Healthcare and Siemens Healthcare. Market segmentation by end‑use and technology provides a granular view of how full‑body CT systems are integrated across clinical workflows. It also analyzes product innovation metrics including AI enhancement rates, adoption of photon‑counting technology, and usage of hybrid imaging units. Coverage extends to market dynamics such as drivers, restraints, opportunities, and challenges, each quantified with percentage‑based insights and industry adoption data. Trend analysis incorporates adoption rates of advanced systems across global regions, along with projections on scan volumes and system installations in hospitals and clinics. The report also explores investment and financing patterns propelling technology deployment and service expansion, offering a robust framework for strategic decision‑making in the Full‑body CT Market.